FinTrust Capital Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$2.2K Sell
115
-3
-3% -$62 ﹤0.01% 1201
2024
Q2
$2.44K Sell
118
-15
-11% -$298 ﹤0.01% 1167
2024
Q1
$2.5K Buy
133
+48
+56% +$824 ﹤0.01% 1080
2023
Q4
$1.23K Sell
85
-50
-37% -$680 ﹤0.01% 1123
2023
Q3
$2.34K Sell
135
-58
-30% -$1.21K ﹤0.01% 996
2023
Q2
$5.39K Hold
193
﹤0.01% 859
2023
Q1
$5.39K Hold
193
﹤0.01% 853
2022
Q4
$5.39K Sell
193
-6
-3% -$153 ﹤0.01% 851
2022
Q3
$5K Buy
199
+17
+9% +$513 ﹤0.01% 1023
2022
Q2
$6K Hold
182
﹤0.01% 1008
2022
Q1
$6K Hold
182
﹤0.01% 1043
2021
Q4
$6K Sell
182
-21
-10% -$684 ﹤0.01% 1004
2021
Q3
$7K Sell
203
-172
-46% -$5.5K ﹤0.01% 976
2021
Q2
$11K Buy
+375
New +$12.3K ﹤0.01% 921

Other funds holding OGN

FinTrust Capital Advisors's OGN Position: Q3 2024 in Review

FinTrust Capital Advisors reduced its Organon & Co (OGN) stake by 2.5% in Q3 2024, selling an estimated $62 and leaving 115 shares worth $2.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1201.

FinTrust Capital Advisors first reported a position in OGN in Q2 2021 and has held it in 14 quarters since. The position peaked at $11K in Q2 2021. 723 funds tracked by Wall St. Rank hold OGN as of Q3 2024.

  • FinTrust Capital Advisors held 115 shares of Organon & Co worth $2.2K as of Q3 2024.
  • FinTrust Capital Advisors sold 3 Organon & Co shares in Q3 2024, an estimated $62.
  • Organon & Co made up ﹤0.01% of FinTrust Capital Advisors's portfolio in Q3 2024, its #1201 holding.
  • FinTrust Capital Advisors first reported a position in Organon & Co in Q2 2021 and has held it in 14 quarters since.
  • FinTrust Capital Advisors's Organon & Co position peaked at $11K in Q2 2021.
  • 723 funds tracked by Wall St. Rank held Organon & Co as of Q3 2024.

Based on FinTrust Capital Advisors's 13F filing for Q3 2024, filed 11 Oct 2024.